IBA has entered into a partnership with HIL Medical to prepare for laser based PT beam technology turning a "huge system" to a powerful "desktop product". IBA has also reported solid H2 numbers today and reiterated its guidance of 20% top line growth and expects margins to be between 13% - 15% by 2018. We leave our estimates for 2016 and beyond unchanged for now. IBA is preparing for the third step in its efforts to replace RT with PT. This could make our long term PT penetration rate of 30% loo ....
25 Aug 2016
The triple step to replace linacs entirely
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
The triple step to replace linacs entirely
Ion Beam Applications SA (IBAB:BRU) | 0 0 (-0.5%) | Mkt Cap: 680.7m
- Published:
25 Aug 2016 -
Author:
Martin Brunninger -
Pages:
15
IBA has entered into a partnership with HIL Medical to prepare for laser based PT beam technology turning a "huge system" to a powerful "desktop product". IBA has also reported solid H2 numbers today and reiterated its guidance of 20% top line growth and expects margins to be between 13% - 15% by 2018. We leave our estimates for 2016 and beyond unchanged for now. IBA is preparing for the third step in its efforts to replace RT with PT. This could make our long term PT penetration rate of 30% loo ....